MedTrace Logo

Development and Evaluation of a Smart Technology-Assisted System for Shoulder Joint Physical Therapy Assessment

NCT07089082 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 40

Last updated 2025-07-28

No results posted yet for this study

Summary

Shoulder pain is one of the most prevalent musculoskeletal conditions. Evidence-based medicine has identified physical therapy as the most effective intervention for managing shoulder disorders. To ensure accurate diagnosis and effective treatment planning, a comprehensive evaluation that integrates various clinical findings is essential. Without timely and accurate diagnosis and intervention, shoulder pain may recur and fail to improve, limiting therapeutic outcomes.

With technological advancements, the application of mobile devices and artificial intelligence (AI) in clinical settings has become increasingly widespread. Motion capture technologies integrated into mobile platforms offer emerging solutions for clinical challenges. If clinicians are equipped with an intelligent system for shoulder assessment and intervention-one that includes image-based quantitative assessment tools, evidence-based clinical guidelines and data repositories, and home-based rehabilitation support-it may enhance diagnostic precision, increase clinical efficiency, and improve patient adherence to home exercise programs.

The aim of this study is to develop a smart technology-assisted assessment system for orthopedic physical therapy of the shoulder joint and to validate its reliability and validity. This system will provide clinicians with objective, data-driven evaluation results. In future development, it will also offer support in treatment goal setting, intervention planning, and home-based exercise guidance. The proposed intelligent system is expected to serve as an evidence-based clinical aid, enhancing both the precision and efficiency of physical therapy interventions.

Conditions

  • Shoulder

Sponsors & Collaborators

  • National Cheng-Kung University Hospital

    lead OTHER

Eligibility

Min Age
20 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-07-01
Primary Completion
2026-05-28
Completion
2026-07-31

Countries

  • Taiwan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07089082 on ClinicalTrials.gov